Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhilong Tongluo Tablets for Ischemic Stroke (Qi Deficiency and Blood Stasis Pattern) Phase III Trial
CTR20254964Phase 3Active
- Sponsor
- Tongyu Kangtai
- Start
- Dec 2025
- Countries
- 1
01
Overview
A Phase 3 trial of Zhilong Tongluo in ischemic stroke, sponsored by Tongyu Kangtai. Started Dec 2025; status: active.
02
Drugs
Zhilong Tongluo
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20254964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254964.